• No results found

The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo

N/A
N/A
Protected

Academic year: 2020

Share "The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo"

Copied!
17
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 (See legend on next page.)
Fig. 2 DMAMCL induces RMS cell death via apoptosis in vitro.7.5phases is shown.evaluated
Fig. 3 (See legend on next page.)
Fig. 4 (See legend on next page.)
+5

References

Related documents

Cite this article as: Cheng et al.: Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of

Thus, reducing the rate of redundant admissions by using external information produced larger odds ratios (of the β coefficients; e.g. viewing external information on patients

This retrospective chart review of reasons that surgery was cancelled after the patient had been prepared for surgery showed that the most common reason for cancellation was

hanced by the BCG vaccine [17] and is not being studied for the MVA85A vaccine; (b) isoniazid preventive therapy (IPT), as the effect would have been equal in both arms; (c)

Also, both diabetic groups there were a positive immunoreactivity of the photoreceptor inner segment, and this was also seen among control ani- mals treated with a

Due to the continued interest and debate in this area, we conducted a scoping systematic literature review and meta-analysis of all observational studies

Such workloads appear, for example, during the boot process of an operating system, where it checks the integrity of its components (see [‎15] for example). This

The primary end point of the study was the change from baseline in goblet cell density (determined by CIC) over the 3-month treatment period. Exploratory end